ISSCA Announces Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018
(Image: Istanbul, Turkey)
The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium in Istanbul, Turkey April 28, 2018.
MIAMI, Feb 14, 2018—The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium in Istanbul, Turkey April 28, 2018. The symposium will focus on new advances in cell therapies.
The Istanbul international symposium is part of ISSCA’s mission to support a shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.
The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.
To learn more about the ISSCA symposium in Istanbul and to register to attend, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About International Society for Stem Cells Applications
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
Regenerative Medicine symposium Istanbul
- Published in Press Releases
Global Stem Cells Group to Launch Regenerative Medicine Training Program for Mexico at Congreso Internacional de Medicina Antienvejecimiento y Longevidad
(Image: Regenerative Medicine Training Program for Mexico)
MIAMI, Feb. 14, 2018— Global Stem Cells Group, a world leader in stem cell and regenerative medicine, will launch the organization’s complete Regenerative Medicine Training Program for Mexico at the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad (Congress in Anti-Aging and Longevity Medicine) to be held February 16 – 18, 2018 in Mexico City.
The training course will be held in Mexico City April 13 – 14, 2018.
The “Practical Course of Cell Therapies in a Clinical Environment” is a two-day, hands-on training course that provides physician attendees with the intellectual property of 22 proprietary protocols that allow treatment procedures for degenerative and aesthetic conditions and diseases in-office, as well as step-by-step videos of each protocol.
Course attendees will acquire the skills that will allow them to offer alternative therapies to patients who suffer from degenerative conditions for which no traditional medical solutions are available. Attendees will treat three to five live patients during the course. Upon completing the course successfully, participants will join a select group of physicians at the forefront of medical science—only 5 percent of physicians worldwide have access to studies of cell therapies, and only 0.01 percent are currently practicing these therapies.
Qualified physicians learn skills that can be used to treat patients in-practice, and utilize the training for career advancement.
Participating physicians will also receive access to the online stem cell training course to review all content and procedures introduced in the 2-day clinical training course, patient forms and guidelines, procedure informed consent forms, didactic lectures, training booklets, and more.
The Regenerative Medicine Training Program for Mexico was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells. Stem cell therapies continue to revolutionize the healthcare industry and help improve the quality of life for patients.
To learn more about the certification training course and register to participate, visit the Stem Cell Training Course website, email info@stemcellsgroup.com, or call 305-560-5337.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Regenerative Medicine Training for Mexico
- Published in Press Releases
Global Stem Cells Group CEO Benito Novas to be a Keynote Speaker at Congreso Internacional de Medicina Antienvejecimiento y Longevidad Feb. 16-18, 2018
Benito Novas, Global Stem Cells Group CEO
MIAMI, Feb. 14, 2018— Global Stem Cells Group founder and CEO Benito Novas will be a keynote speaker at the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad (Congress in Anti-Aging and Longevity Medicine) February 16 – 18, 2018 in Mexico City. The conference is organized by The Institute of Anti-Aging and Longevity Medicine, the leading anti-aging and regenerative medicine society in Mexico.
Novas, a global entrepreneur and medical marketing professional in the fields of biotechnology, life sciences, and healthcare development, will share his expertise on the latest marketing tools for managing a medical practice. Topics will include social media strategies and tools for promoting physician practices, and how to design Google and Facebook ads that generate targeted leads and engage new potential patients.
The healthcare industry is continuously pursuing new and improved medical and technological advancements, treatments, and expanded healthcare opportunities that offer a higher level of patient care. The industry serves a uniquely broad audience, and today’s consumers are searching online for medical providers.
In fact, the majority of consumers rely on the internet to find healthcare providers.
For this reason, Novas says it is critical for medical practices and providers to stay on top of digital marketing strategies and trends in order to keep their organizations competitive and to generate new leads in today’s patient-centric market.
Novas will join healthcare professionals from around the world who specialize in treatments for conditions and diseases affecting aging and elderly patients from around the world for the anti-aging conference in Mexico City later this month.
Instituto de Medicina Antenvejecimiento Longevidad
The conference will be held at Hotel Reforma in Mexico City.
To learn more or register for the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad, visit the conference website. For information on Benito Novas and regenerative and stem cell medicine, visit the Global Stem Cells Group website, email info@stemcellsgroup.com, or call +1 305 560 5337.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Benito Novas keynote speaker
- Published in Press Releases
Global Stem Cells Group to Sponsor Congreso Internacional de Medicina Antienvejecimiento y Longevidad Feb. 16-18, 2018
(Image: Hotel Reforma, Mexico City)
MIAMI, Feb. 14, 2018— Global Stem Cells Group, a world leader in stem cell and regenerative medicine, will sponsor the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad (Congress in Anti-Aging and Longevity Medicine) to be held February 16 – 18, 2018 in Mexico City. This will be the third consecutive year GSCG is sponsoring the Congress.
Global Stem Cells Group founder and CEO Benito Novas will join healthcare professionals from around the world for the event. Anti-aging medicine focuses on early detection, prevention, treatment, and regeneration for conditions related to advanced age and promotes. innovative therapy and protocol development for the therapeutic management of aging and elderly patients. Four-hundred participants are expected to attend.
Instituto de Medicina Antenvejecimiento Longevidad
A lineup of world-renowned physicians, all leaders in anti-aging medicine, will teach magisterial conferences throughout the event. There will also be practical theoretic workshops related to anti-aging, regenerative, and aesthetic medicine. Additionally, conference attendees will be able to witness various procedures performed by expert anti-aging practitioners.
The conference is organized by The Institute of Anti-Aging and Longevity Medicine, the leading anti-aging and regenerative medicine society in Mexico.
IX Congress attendees will be granted recognition for their participation and will have access to the event’s commercial area where they can purchase products and learn about business opportunities with leading national and international companies specializing in anti-aging medicine.
The conference will be held at Hotel Reforma in Mexico City.
To learn more or register for the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad, visit the conference website. For information on regenerative and stem cell medicine, visit the Global Stem Cells Group website, email info@stemcellsgroup.com, or call +1 305 560 5337.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Congress in Anti-Aging and Longevity Medicine
- Published in Press Releases
Global Stem Cells Group names Mehmet Veli Karaaltın, M.D. to Advisory Board
(Image: Mehmet Veli Karaaltın, M.D.)
MIAMI, Jan. 18, 2018—Global Stem Cells Group CEO Benito Novas has named Mehmet Veli Karaaltın, M.D., Associate Professor of Plastic, Aesthetic, and Reconstructive Surgery, (European Board Certified), and hand surgery, head, and maxillofacial surgery specialist to the GSCG Advisory Board Faculty.
Karaaltın practices in Istanbul, Turkey.
Born in Iraq-Kirkuk in 1972, Karaaltın moved to the United States with his family, living in West Lafayette, Indiana and Los Angeles until 1988, when he moved to Istanbul.
After graduating from Istanbul University’s Cerrahpaşa English Medical Faculty, Karaaltın received a national examination from Hacettepe University in Ankara, Turkey, where he was 12th out of 25000 doctoral candidates. In 2012, he passed and completed all ID exams required by the European Society of Plastic Surgery. He is a member of the European Council of Plastic Reconstructive and Aesthetic Surgery and the International Society of Aesthetic Plastic Surgery (ISAPS).
In addition to his work in aesthetic applications, Karaaltın is also known for his work in microvascular free flaps, nerve transfers, facial surgery, and tissue transplants.
Karaaltın also practices cellular therapy and tissue regeneration for healing diabetic wounds, severe burns, and Buerger’s disease. He is one of only a few physicians in the world who offer surgical treatment for Lymphedema-Elephant Disease with microvascular lymph node transfer. In addition, Karaaltın uses
3-D technology to perform aesthetic rhinoplasty.
“It is a pleasure to welcome Dr. Karaaltın to the Global Stem Cells Group Advisory Board,” says GSCG CEO Benito Novas. “He brings a wealth of knowledge in aesthetic regenerative medicine to the table, and we look forward to a long and productive alliance.”
To learn more, visit the Global Stem Cells Group website, email inf@stemcellsgroup.com, or call +1 305 560 5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Mehmet Veli Karaaltın, M.D.
- Published in Press Releases
ISSCA President Daeyong Kim, Ph.D. Announces Next Chapter Meeting to be Held Jan. 24 – 26, 2018 in Seoul, Korea
ISSCA President Daeyong Kim, Ph.D., and Vice President Benito Novas to hold next ISSCA chapter meeting in Seoul, Korea Jan. 24-26, 2018.
MIAMI, Jan. 18, 2018— ISSCA President Daeyong Kim, Ph.D. has announced the next chapter meeting will be held Jan. 24 – 26, 2018 in Seoul, Korea.
The meeting will be held by Kim and ISSCA Vice President Benito Novas and will address all ISSCA chapter directors and board members.
ISSCA Chapter directors from the U.S., Costa Rica, Argentina, Spain, and Morocco will be in attendance. During the three-day event, chapter directors will receive training in the latest regenerative medicine clinical application protocols as well as applications for manipulating and harvesting stem cells in lab conditions.
ISSCA will also establish strategies for 2018, focusing on promoting excellence and setting standards in the field of publication, research, related education, and certification in regenerative medicine during the event.
The organization intends to set the entire 2018 agenda for regenerative medicine training for 2018 during the meeting, including:
• The Hands on Training Agenda
• The Cell Therapy and Engineering Tissue Fellowship
To learn more about ISSCA, visit the stemcellglobal.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
ISSCA chapter meeting
- Published in Press Releases
ISSCA President Daeyong Kim, Ph.D. Names Junaid Sayed, M.D. President of ISSCA’s U.S. Chapter
(Image: Junaid A. Syed, M.D.)
ISSCA President Daeyong Kim, Ph.D., has named Junaid Sayed, M.D. president of ISSCA’s U.S. chapter.
MIAMI, Jan. 18, 2018—International Society for Stem Cell Application (ISSCA) President Daeyong Kim, Ph.D., has named Junaid Sayed, M.D. president of ISSCA’s U.S. chapter. Sayed is Board Certified physician with extensive training in aesthetic medicine.
As president of the U.S. chapter, Sayed will represent and promote ISSCA activities the USA, including ISSCA’s Stem Cell Certification Training and Stem Cell Conference events. He will also share the latest information on regenerative medicine clinical applications with the U.S, medical community.
“We are happy to have Dr. Sayed represent ISSCA in the U.S., and as a collaborator in our efforts to introduce new clinical applications to the medical community,” says Kim. “He brings a wealth of experience and expertise to the ISSCA organization.”
To learn more about ISSCA, visit the stemcellglobal.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
- Published in Press Releases
STEM CELL CENTER ANNOUNCES TWO NEW MEDICAL DIRECTORS IN THEIR MOROCCAN AND BAGHDAD OFFICES
For Immediate Release: July 19, 2017
Contact: Mr Benito Novas
info@stemcellsgroup.com
+1 305 560 5337
STEM CELL CENTER ANNOUNCES TWO NEW MEDICAL DIRECTORS IN THEIR MOROCCAN AND BAGHDAD OFFICES
Morocco – Stem Cell Center, a subsidiary organization from the Global Stem Cells Group international network of doctors, practitioners, researchers, and other passionate stem cell research personnel, this week excitedly announced they have appointed a new medical director at both their operations in Morocco and Baghdad. Now welcoming Professor Yasser Safiani in Morocco, and Mazin Shakir Mahmood MD in Iraq, the Stem Cell Center network expanded out this week.
Borne from a passion for constantly working to expand and contribute to the study of regenerative medicine in our world today, Stem Cell Center oversees workshops, fellowships, seminars, and more for sharing the organization’s new stem cell findings.
“We are incredibly excited to be welcoming two greatly esteemed individuals into our network,” said Benito Novas, Founder and Owner of Stem Cell Center. “These are two individuals who, combined, bring more than 6-decades of immersive training and experience in medical fields, specifically regenerative medicine. We are incredibly excited to be working with them as our medical directors.”
Dr. Mahmood received his Bachelor’s Degree from the Baghdad College of Medicine in 1988. From there, he pursued a post-graduate degree in medicine at the University of Baghdad, and went to work as an Iraqi commissioner for medical specializations, as well as a professor for the German Hear Center. In 2010, he returned to Iraq and established his private center, which is still in operation today.
Professor Sefiani completed his primary education at Guessous in 1979. From there, he pursued a scientific Bachelor’s Degree, and became a medical faculty member at Rabat. Today, he is an esteemed professor of cardiovascular education, and he brings with him close to 4-decades of education experience.
For more information, visit: https://stemcellcenter.net/.
- Published in Press Releases
GLOBAL STEM CELLS GROUP TO HOLD NEW INTERNATIONAL SYMPOSIUM IN CASABLANCA
For Immediate Release: July 20, 2017
Mr Benito Novas, Global Stem Cells Group, CEO
info@stemcellsgroup.com
+1 305 560 5337
GLOBAL STEM CELLS GROUP & INTERNATIONAL SOCIETY FOR STEM CELLS APPLICATIONS TO HOLD NEW INTERNATIONAL SYMPOSIUM IN CASABLANCA
Casablanca, Morocco – Global Stem Cells Group, an international network of physicians, researchers, and medical advocates all working together to advance the study and application of regenerative medicine today, this week announced in conjunction with the International Society for Stem Cells Application (ISSCA), they will be hosting a new International Symposium in Casablanca, Morocco.
With the exact date and location to be confirmed in the forthcoming months, the two organizations expressed their excitement and encouragement for the already confirmed guests and presenters.
“There can never be enough discourse and exchange between the top performing stem cells researchers and practitioners in our world today,” said Mr. Benito Novas, Founder and Owner of Global Stem Cells Group. “We have elected to host our new symposium in Morocco because we feel it is a great platform from which we can share the latest news about regenerative medicine with people from North Africa.”
Passionate about bringing the unmatched healing and advanced medical properties of stem cell application to every region around the world, Global Stem Cells Group will be focusing their efforts on North Africa with the upcoming symposium. Already, the group has reported they expect more than 1,000 physicians to attend the comprehensive event, with keynote speakers and hands-on workshops to be accessible to those in attendance.
The ISSCA and Global Stem Cells Group endorsed event will provide cutting-edge information on developments in all areas of stem cell research, including biology, applications, regulations, product development, and the ongoing commercialization of stem cells.
“This event will present invaluable networking and collaborative opportunities for those in attendance,” said Mr. Novas. “Stay tuned for official event details.”
For more information, visit: stemcellconference.org.
- Published in Press Releases
GLOBAL STEM CELLS GROUP OPENS NEW MEDICAL OFFICE IN CASABLANCA, MOROCCO
For Immediate Release: July 9, 2017
Contact: Benito Novas
info@stemcellsgroup.com
+1 305 560 5337
GLOBAL STEM CELLS GROUP OPENS NEW MEDICAL OFFICE IN CASABLANCA, MOROCCO
Casablanca – Global Stem Cells Group, an international network of doctors, practitioners, educators, and researchers all working cohesively to advance the implementation of regenerative medicine in our world today, this week announced under their subsidiary organization, Stem Cells Center, they are opening a brand new medical office in Casablanca, Morocco.
As part of the new office opening, Stem Cells Center will be partnering with LBL Medical in the Zone Industrialle Comune Urbaine.
“As an organization that is constantly working to reach as many people as possible with our regenerative medicinal breakthroughs and newly discovered information, we are absolutely elated to be opening a full-service medical office right in North Africa,” said Benito Novas, Founder and Owner of Global Stem Cells Group. “We plan to use this new medical office to expand our networking opportunities in North Africa, and introduce our workshops, seminars, and fellowships available in many different stem cells fields.”
The Casablanca medical office will primarily help treat people living with degenerative illnesses. The main goal is to assess and address the illnesses by working towards improving the quality of life through regenerative medicine. The Casablanca team will work closely with patients, educators, physicians, regulators, and policymakers in the region to foster engagement and develop materials that promote stem cell technology.
Additionally, the new office will function as a regenerative medicine reference in North Africa, providing doctors with medical instruction regarding stem cells. For those wishing to implement stem cell oversight, they will be able to visit the office and collaborate with doctors, as well as participate in educational classes and workshops, to successfully bring back regenerative medicinal practices to their own clinics.
“Our offices are about more than working alongside our patients – they’re about spreading our discoveries, information, and research with as many eager and willing doctors as possible,” said Novas. “We are primarily an educational institution with a passion for advancing our regenerative industry as far and wide as possible. Spread the word on the official opening of our new Casablanca office, and consider stopping by at any convenient time in the future.”
Global Stem Cells Group is regarded as the first choice for readily accessible stem cell medicine around the world today. The network is comprised of the world’s leading physicians and medical practitioners that participate in constant therapy, research, and studying.
For more information, visit: https://stemcellcenter.net/.
- Published in Press Releases